Ignite Creation Date:
2025-12-25 @ 12:54 AM
Ignite Modification Date:
2026-01-01 @ 9:44 PM
Study NCT ID:
NCT03175367
Status:
COMPLETED
Last Update Posted:
2023-02-10
First Post:
2017-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-14
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-01
First Submit QC Date:
None
Study First Post Date:
2017-06-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-19
Results First Submit QC Date:
None
Results First Post Date:
2023-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-02-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-01-27
Last Update Post Date:
2023-02-10
Last Update Post Date Type:
ACTUAL